Sorafenib Tosylate

FDA Approved: * September 10, 2020
Pharm Company: * MYLAN
Category: Cancer

Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. Contents 1 Mechanism of action 2 Medical uses 2.1 Kidney cancer 2.2 Liver cancer 2.3 Thyroid cancer 2.4 Desmoid tumors 3 Adverse effe... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Sorafenib Tosylate 200 mg Oral Tablet, Film Coated
NDC: 0378-1201
Mylan Pharmaceuticals Inc.
Sorafenib 200 mg Oral Tablet, Film Coated
NDC: 0480-5425
Teva Pharmaceuticals, Inc.
Sorafenib 200 mg Oral Tablet, Film Coated
NDC: 43598-458
Dr.reddys Laboratories Inc

Related Brands

Drugs with the same active ingredients

Popular Topics

How many people in USA using Sorafenib Tosylate?

Hi, Does anyone know how many people take this medicine in USA? How about its effect? How mean generally how long it can...

sorafeniband side effects

Been on it for 9 months. Acne on the face became bad and lowered dose. Wondering if that's OK with the b17 and sours...